BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Center For Technology Licensing - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://ctl.cornell.edu
X-WR-CALDESC:Events for Center For Technology Licensing
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20210101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20210319T120000
DTEND;TZID=UTC:20210319T130000
DTSTAMP:20260404T103243
CREATED:20210205T020321Z
LAST-MODIFIED:20210205T020321Z
UID:10000223-1616155200-1616158800@ctl.cornell.edu
SUMMARY:CTL IP Series 2: What is Patent Eligible in the U.S.?
DESCRIPTION:CTL IP Series 2: What is Patent Eligible in the U.S.?\n3/19/2021 from 12 pm to 1 pm (EST)\nFor this second virtual meeting of the IP series\, Dr. John D. Lopinski\, Partner at Hodgson Russ LLP\, will present an overview of patent eligible subject matter and will provide some examples to illustrate issues related to patent eligibility. \n  \nDr. John D. Lopinski will be joined by Bill Pegg\, Associate Director for IP at CTL. \n  \nTopics includes: \n\nOverview of patent eligible subject matter\nChallenges in obtaining patent eligibility in Life Sciences (e.g.\, Diagnostics\, Antibodies\, etc.)\nChallenges in obtaining patent eligibility in Physical Sciences (e.g.\, Electronics\, Encryption\, Blockchain\, Crypto\, Software\, etc.)\n\nSpeakers:  \n\nJohn D. Lopinski\, Ph.D.\, Partner\, Hodgson Russ LLP\nBill Pegg\, Associate Director for IP\, CTL\n\nRegister: https://cornell.zoom.us/meeting/register/tJIvceGorzkvHNLcq6R-OWzbWwFxyhS4eLud
URL:https://ctl.cornell.edu/event/ctl-ip-series-2-what-is-patent-eligible-in-the-u-s
CATEGORIES:CTL Events
END:VEVENT
END:VCALENDAR